Sort
261,768 grants matching “gene therapy”
Phase 1 Study of DNX-2440 for Resectable Colorectal Liver Metastasis - IND 018569
$852,568Joan Marie Robbins · Dnatrix, Inc. · R44 · FY2022 · CA
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
$852,537Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Sex and stress hormones control adrenal gland macrophage development and function"
$852,525Jesse Warren Williams · University Of Minnesota · R01 · FY2025 · AI
Developing Transmissible Antivirals by Exploiting Gene-Expression Circuitry
$852,500Leor S Weinberger · University Of California, San Diego · DP2 · FY2009 · OD
Genetically-engineered pig orthotopic (life-supporting) heart transplantation (OHTx) in baboons: establishing consistent graft survival and overcoming rapid post-Tx organ growth
$852,474Muhammad M Mohiuddin · Massachusetts General Hospital · U19 · FY2023 · AI
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$852,400Suresh S Ramalingam · Emory University · UG1 · FY2019 · CA
New approaches to kidney banking through nature-inspired high sub-zero preservation strategies
$852,392Bradley P Weegman · Expanse Bio Llc · R44 · FY2025 · DK
ApoVax104-HPV as a Novel Vaccine for Cervical Cancer
$852,358Kathryn J. Macleod · Apovax, Inc. · R44 · FY2009 · AI
Role of proviral loci in HIV latency
$852,198James Ivan Mullins · University Of Washington · R01 · FY2017 · AI
Regulation of Aldosterone: The Effect of Statins
$852,185Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2017 · HL
Opaganib as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome
$852,174Charles D Smith · Apogee Biotechnology Corporation · R44 · FY2023 · AI
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
$852,159Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2025 · DK
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2021 · DK
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2022 · DK
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2024 · DK
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2023 · DK
TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis
$852,124Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Interdisciplinary Tumor Complexity Modeling
$852,051E. Antonio Chiocca · Ohio State University · R01 · FY2006 · CA
Biological pacemaker from proof-of-concept to clinic
$852,020Eugenio Cingolani · Cedars-Sinai Medical Center · R01 · FY2020 · HL
Mammalian iron-sulfur cluster biogenesis
$851,972Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
Reverse Genetics To Forward The Pan-Lassa Fever Vaccine Lead Candidate ML29
$851,962Slobodan Paessler · University Of Texas Med Br Galveston · R56 · FY2018 · AI
TOLERANCE TO COMPOSITE ISLET-KIDNEY TRANSPLANTS IN BABOONS
$851,906David H Sachs · Massachusetts General Hospital · U01 · FY2010 · DK
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$851,904Jonah B. Sacha · Oregon Health & Science University · R01 · FY2017 · AI
Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.
$851,900Sung Ok Yoon · Ohio State University · R01 · FY2017 · AG